HM Payson & Co’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
HM Payson & Co's RGEN Position: Q1 2022 in Review
HM Payson & Co sold out of Repligen (RGEN) in Q1 2022, closing a stake of 97 shares — an estimated $26K sold.
HM Payson & Co first reported a position in RGEN in Q3 2020 and held it in 4 quarters. The position peaked at $41K in Q1 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- HM Payson & Co reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- HM Payson & Co sold 97 Repligen shares in Q1 2022, an estimated $26K.
- HM Payson & Co first reported a position in Repligen in Q3 2020 and held it in 4 quarters.
- HM Payson & Co's Repligen position peaked at $41K in Q1 2021.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.